logo
Select company
Select metric
24.06%Cash to Assets Ratio
VS
Market
79
Sector
52
Industry
40
History
32
$ 18.4Close
$ 9.44 - $ 18.62 52-Week Range
Ticker Information

Ticker

ZYME

Company Name

ZYMEWORKS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZYMEWORKS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZYME - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 408.38M$ 98.25M24.06%
3/31/2025$ 425.52M$ 76.2M17.91%
12/31/2024$ 463.09M$ 66.1M14.27%
9/30/2024$ 487.15M$ 122.36M25.12%
6/30/2024$ 515.63M$ 70.96M13.76%
3/31/2024$ 553.75M$ 114.81M20.73%
12/31/2023$ 580.88M$ 157.56M27.12%
9/30/2023$ 556.37M$ 94.33M16.96%
6/30/2023$ 602.05M$ 142.1M23.6%
3/31/2023$ 600.74M$ 181.58M30.23%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZYMEWORKS INC's latest trailing twelve months (TTM) Cash to Assets stands at 42.7%.
  • Over the past 5 years, ZYMEWORKS INC's average Cash to Assets has been 36.85%.
  • The median Cash to Assets for ZYMEWORKS INC during this period was 31.11%
  • ZYMEWORKS INC reached its highest Cash to Assets over the past 5 years at 64.08%.
  • The lowest Cash to Assets recorded by ZYMEWORKS INC in the same timeframe 13.76%

ZYMEWORKS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
CRMD : CORMEDIX INC 63.07%NAGE : NIAGEN BIOSCIENCE INC 66.07%URGN : UROGEN PHARMA LTD 45.03%ANAB : ANAPTYSBIO INC 13.21%PHAT : PHATHOM PHARMACEUTICALS INC 60.92%GERN : GERON CORP 14.34%SNDX : SYNDAX PHARMACEUTICALS INC 18.26%NRIX : NURIX THERAPEUTICS INC 15.2%GYRE : GYRE THERAPEUTICS INC 23.91%XNCR : XENCOR INC 5.09%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ZYMEWORKS INC is calculated as follows: CashnEq [ $ 244.12M ] / Assets [ $ 571.72M ]
(=) Cash to Assets [ 42.7% ]

ZYME - Cash to Assets Ratio, Last 5 years

13.76%

Minimum

Jun 30, 2024

64.08%

Maximum

Mar 31, 2022

36.85%

Average

31.11%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%